Nusinersen enables infants with SMA to regain motor function
Infants with SMA are more likely to show gains in motor function and survive without assisted support when treated with nusinersen...
List view / Grid view
News
Topical valsartan found to be effective in accelerating chronic wound healing
A topical gel made from a class of common blood pressure medications has been found to accelerate the healing process of chronic skin wounds...
Plastic nanoparticles could improve cancer drug delivery
Scientists have developed self-assembling polymer molecules - an advance that could improve the delivery of toxic drugs to tumours...
Anabasum shows promise for patients with dermatomyositis
A new treatment for dermatomyositis reduced the severity of the disease in patients who were resistant to other therapies...
FDA approves Calquence for adults with mantle cell lymphoma
The FDA has granted accelerated approval to Calquence for the treatment of adults with mantle cell lymphoma...
Long-term use of PPIs linked to stomach cancer
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer...
Wickham Laboratories announces expansion of media preparation facilities
Wickham Laboratories expands capacity for in-house media preparation...
Systematic review looks at the effectiveness and side effects of mefloquine
Researchers have published two systematic reviews revealing the safety of mefloquine for preventing malaria in travellers...
Exhibitors count down the days to Lab Innovations 2017
It’s less than a week before Lab Innovations 2017 begins, and preparations are in full swing as the NEC Birmingham gets ready to open its doors and welcome over 130 exhibitors showcasing the latest analytical, biotech and laboratory products...
Almac Group announces successful MHRA inspection at Charnwood facilities
Almac Group, the Craigavon based global contract pharmaceutical development and manufacturing organisation, is pleased to announce the successful inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) of its new Pharmaceutical Development & Manufacturing facilities at Charnwood Campus, Loughborough...
Focused ultrasound shows promise for treating Parkinson’s tremor
Study examines potential of scalpel-free surgery to manage tremor...
Smart artificial beta cells could lead to new diabetes treatment
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
FDA approves new dosing for Xarelto to reduce the risk of VTE
The FDA has approved the 10 mg once-daily dose of Xarelto, for reducing the continued risk of recurrent venous thromboembolism...
New treatments help those with mild, moderate and severe eczema
Crisaborole and dupilumab approved for atopic dermatitis…
New initiative to accelerate development of universal influenza vaccines
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
